Comparison
Why is ZYUS Life Sciences Corp. ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
8.16%
EBIT Growth (5y)
-268.72%
EBIT to Interest (avg)
-3.15
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.50
Sales to Capital Employed (avg)
0.09
Tax Ratio
15.55%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.08%
ROCE (avg)
0
ROE (avg)
1.57%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-4.13
EV to EBIT
-3.40
EV to EBITDA
-4.21
EV to Capital Employed
50.74
EV to Sales
50.74
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1492.80%
ROE (Latest)
Negative BV
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Technical Movement
7What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CAD -9.79 MM
NET PROFIT(HY)
Higher at CAD -6.49 MM
RAW MATERIAL COST(Y)
Fallen by -4.37% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -157.36 %
-13What is not working for the Company
INTEREST(HY)
At CAD 0.8 MM has Grown at 217.93%
NET PROFIT(HY)
At CAD -6.49 MM has Grown at -28.43%
ROCE(HY)
Lowest at -546.27%
CASH AND EQV(HY)
Lowest at CAD 2.56 MM
Here's what is working for ZYUS Life Sciences Corp.
Net Profit
Higher at CAD -6.49 MM
than preceding 12 month period ended Mar 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (CAD MM)
Operating Cash Flow
Highest at CAD -9.79 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CAD MM)
Debt-Equity Ratio
Lowest at -157.36 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -4.37% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for ZYUS Life Sciences Corp.
Interest
At CAD 0.8 MM has Grown at 217.93%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CAD MM)
Net Profit
At CAD -6.49 MM has Grown at -28.43%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (CAD MM)
Cash and Eqv
Lowest at CAD 2.56 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents






